U.S. researchers replicated Alzheimer's disease neurons using induced pluripotent stem cells from patients with the genetic and sporadic forms of the disease, according to a report in the journal Nature. The study found early abnormalities are caused not by beta-amyloid fragments but by a precursor to the fragments called beta-CTS, a researcher said. The neurons could help in drug testing.

Full Story:

Related Summaries